Eton Pharmaceuticals, Inc. - COM (ETON)

Historical Portfolio Holders from Q4 2018 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
8.23M
Holdings value Q2 2024
$27.1M
Value change Q2 2024
+$3.4M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
44
Number of buys Q2 2024
13
Number of sells Q2 2024
-22
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 8.23M $27.1M +$3.4M $3.29 44
2024 Q1 7.18M $26.9M -$87.3K $3.75 43
2023 Q4 7.16M $31.4M +$1.22M $4.38 55
2023 Q3 6.9M $28.8M +$3.93M $4.17 50
2023 Q2 5.98M $20.9M +$440K $3.49 33
2023 Q1 5.84M $22.5M +$148K $3.85 34
2022 Q4 5.94M $16.7M -$1.03M $2.82 31
2022 Q3 6.05M $12.7M +$550K $2.10 28
2022 Q2 5.27M $13.8M -$20.2K $2.62 25
2022 Q1 5.48M $23.9M +$177K $4.36 27
2021 Q4 5.43M $23.3M -$881K $4.29 28
2021 Q3 5.96M $32.6M -$4.92M $5.04 36
2021 Q2 6.84M $51.8M -$13M $6.16 43
2021 Q1 8.79M $68M +$241K $7.32 49
2020 Q4 8.73M $70.9M +$13.6M $8.13 45
2020 Q3 6.46M $51M +$511K $7.90 34
2020 Q2 6.8M $37.1M +$4.61M $5.45 40
2020 Q1 5.97M $24.5M +$13.6M $4.10 17
2019 Q4 2.62M $18.9M +$2.67M $7.20 13
2019 Q3 2.28M $14.4M +$3.21M $6.32 13
2019 Q2 1.77M $14M +$2.1M $7.90 10
2019 Q1 1.5M $12M +$2.82M $8.00 12
2018 Q4 1.15M $7.05M +$7.05M $6.12 11